Regal Assets Analytics

SanaCurrents Case Studies

ARMO Biosciences (ARMO) – SanaCurrents Case Study

By |2020-04-23T10:19:50-04:00August 25th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents Case Studies|Tags: , |

ARMO Biosciences (ARMO) listed in January 2018 at $17 per [...]

Read More
 0

Eiger Biopharmaceuticals (NASDAQ:EIGR) – SanaCurrents Case Study

By |2020-04-23T10:19:27-04:00August 10th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents Case Studies|Tags: , |

Eiger Biopharmaceuticals (NASDAQ:EIGR), a company developing treatment for rare diseases, [...]

Read More
 0

MyoKardia (NASDAQ:MYOK) – SanaCurrents Case Study

By |2018-11-25T13:52:30-05:00August 3rd, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents Case Studies|Tags: , , |

MyoKardia (NASDAQ:MYOK), a leading precision cardiovascular medicine company, reported good [...]

Read More
 0

Dynavax’s (NASDAQ:DVAX) – SanaCurrents Case Study

By |2018-11-20T15:37:46-05:00August 1st, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents Case Studies|Tags: , , |

Dynavax's (NASDAQ:DVAX) BLA application for its Hepatitis B vaccine first [...]

Read More
 0

Zogenix (NASDAQ:ZGNX) – SanaCurrents Case Study

By |2018-11-20T15:51:47-05:00July 31st, 2018|Categories: Health Care Equipment & Services, Healthcare, Hot Research, Insights, Pharmaceutical & Biotechnology, SanaCurrents Case Studies|Tags: , , , |

California-based company Zogenix (NASDAQ:ZGNX) observed the drug fenfluramine, which had [...]

Read More
 0
Go to Top